Integrative analysis of genomic alterations in triple-negative breast cancer in association with homologous recombination deficiency.

Triple-negative breast cancer (TNBC) cells do not express estrogen receptors, progesterone receptors, or human epidermal growth factor receptor 2. Currently, apart from poly ADP-ribose polymerase inhibitors, there are few effective therapeutic options for this type of cancer. Here, we present compre...

Full description

Bibliographic Details
Main Authors: Masahito Kawazu, Shinya Kojima, Toshihide Ueno, Yasushi Totoki, Hiromi Nakamura, Akiko Kunita, Wei Qu, Jun Yoshimura, Manabu Soda, Takahiko Yasuda, Natsuko Hama, Mihoko Saito-Adachi, Kazuhito Sato, Shinji Kohsaka, Eirin Sai, Masako Ikemura, Shigeru Yamamoto, Tomoko Ogawa, Masashi Fukayama, Keiichiro Tada, Yasuyuki Seto, Shinichi Morishita, Shoichi Hazama, Tatsuhiro Shibata, Yoshihiro Yamashita, Hiroyuki Mano
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-06-01
Series:PLoS Genetics
Online Access:http://europepmc.org/articles/PMC5500377?pdf=render
_version_ 1811230559209259008
author Masahito Kawazu
Shinya Kojima
Toshihide Ueno
Yasushi Totoki
Hiromi Nakamura
Akiko Kunita
Wei Qu
Jun Yoshimura
Manabu Soda
Takahiko Yasuda
Natsuko Hama
Mihoko Saito-Adachi
Kazuhito Sato
Shinji Kohsaka
Eirin Sai
Masako Ikemura
Shigeru Yamamoto
Tomoko Ogawa
Masashi Fukayama
Keiichiro Tada
Yasuyuki Seto
Shinichi Morishita
Shoichi Hazama
Tatsuhiro Shibata
Yoshihiro Yamashita
Hiroyuki Mano
author_facet Masahito Kawazu
Shinya Kojima
Toshihide Ueno
Yasushi Totoki
Hiromi Nakamura
Akiko Kunita
Wei Qu
Jun Yoshimura
Manabu Soda
Takahiko Yasuda
Natsuko Hama
Mihoko Saito-Adachi
Kazuhito Sato
Shinji Kohsaka
Eirin Sai
Masako Ikemura
Shigeru Yamamoto
Tomoko Ogawa
Masashi Fukayama
Keiichiro Tada
Yasuyuki Seto
Shinichi Morishita
Shoichi Hazama
Tatsuhiro Shibata
Yoshihiro Yamashita
Hiroyuki Mano
author_sort Masahito Kawazu
collection DOAJ
description Triple-negative breast cancer (TNBC) cells do not express estrogen receptors, progesterone receptors, or human epidermal growth factor receptor 2. Currently, apart from poly ADP-ribose polymerase inhibitors, there are few effective therapeutic options for this type of cancer. Here, we present comprehensive characterization of the genetic alterations in TNBC performed by high coverage whole genome sequencing together with transcriptome and whole exome sequencing. Silencing of the BRCA1 gene impaired the homologous recombination pathway in a subset of TNBCs, which exhibited similar phenotypes to tumors with BRCA1 mutations; they harbored many structural variations (SVs) with relative enrichment for tandem duplication. Clonal analysis suggested that TP53 mutations and methylation of CpG dinucleotides in the BRCA1 promoter were early events of carcinogenesis. SVs were associated with driver oncogenic events such as amplification of MYC, NOTCH2, or NOTCH3 and affected tumor suppressor genes including RB1, PTEN, and KMT2C. Furthermore, we identified putative TGFA enhancer regions. Recurrent SVs that affected the TGFA enhancer region led to enhanced expression of the TGFA oncogene that encodes one of the high affinity ligands for epidermal growth factor receptor. We also identified a variety of oncogenes that could transform 3T3 mouse fibroblasts, suggesting that individual TNBC tumors may undergo a unique driver event that can be targetable. Thus, we revealed several features of TNBC with clinically important implications.
first_indexed 2024-04-12T10:30:27Z
format Article
id doaj.art-6a162a70df7847e08883bac287297886
institution Directory Open Access Journal
issn 1553-7390
1553-7404
language English
last_indexed 2024-04-12T10:30:27Z
publishDate 2017-06-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Genetics
spelling doaj.art-6a162a70df7847e08883bac2872978862022-12-22T03:36:51ZengPublic Library of Science (PLoS)PLoS Genetics1553-73901553-74042017-06-01136e100685310.1371/journal.pgen.1006853Integrative analysis of genomic alterations in triple-negative breast cancer in association with homologous recombination deficiency.Masahito KawazuShinya KojimaToshihide UenoYasushi TotokiHiromi NakamuraAkiko KunitaWei QuJun YoshimuraManabu SodaTakahiko YasudaNatsuko HamaMihoko Saito-AdachiKazuhito SatoShinji KohsakaEirin SaiMasako IkemuraShigeru YamamotoTomoko OgawaMasashi FukayamaKeiichiro TadaYasuyuki SetoShinichi MorishitaShoichi HazamaTatsuhiro ShibataYoshihiro YamashitaHiroyuki ManoTriple-negative breast cancer (TNBC) cells do not express estrogen receptors, progesterone receptors, or human epidermal growth factor receptor 2. Currently, apart from poly ADP-ribose polymerase inhibitors, there are few effective therapeutic options for this type of cancer. Here, we present comprehensive characterization of the genetic alterations in TNBC performed by high coverage whole genome sequencing together with transcriptome and whole exome sequencing. Silencing of the BRCA1 gene impaired the homologous recombination pathway in a subset of TNBCs, which exhibited similar phenotypes to tumors with BRCA1 mutations; they harbored many structural variations (SVs) with relative enrichment for tandem duplication. Clonal analysis suggested that TP53 mutations and methylation of CpG dinucleotides in the BRCA1 promoter were early events of carcinogenesis. SVs were associated with driver oncogenic events such as amplification of MYC, NOTCH2, or NOTCH3 and affected tumor suppressor genes including RB1, PTEN, and KMT2C. Furthermore, we identified putative TGFA enhancer regions. Recurrent SVs that affected the TGFA enhancer region led to enhanced expression of the TGFA oncogene that encodes one of the high affinity ligands for epidermal growth factor receptor. We also identified a variety of oncogenes that could transform 3T3 mouse fibroblasts, suggesting that individual TNBC tumors may undergo a unique driver event that can be targetable. Thus, we revealed several features of TNBC with clinically important implications.http://europepmc.org/articles/PMC5500377?pdf=render
spellingShingle Masahito Kawazu
Shinya Kojima
Toshihide Ueno
Yasushi Totoki
Hiromi Nakamura
Akiko Kunita
Wei Qu
Jun Yoshimura
Manabu Soda
Takahiko Yasuda
Natsuko Hama
Mihoko Saito-Adachi
Kazuhito Sato
Shinji Kohsaka
Eirin Sai
Masako Ikemura
Shigeru Yamamoto
Tomoko Ogawa
Masashi Fukayama
Keiichiro Tada
Yasuyuki Seto
Shinichi Morishita
Shoichi Hazama
Tatsuhiro Shibata
Yoshihiro Yamashita
Hiroyuki Mano
Integrative analysis of genomic alterations in triple-negative breast cancer in association with homologous recombination deficiency.
PLoS Genetics
title Integrative analysis of genomic alterations in triple-negative breast cancer in association with homologous recombination deficiency.
title_full Integrative analysis of genomic alterations in triple-negative breast cancer in association with homologous recombination deficiency.
title_fullStr Integrative analysis of genomic alterations in triple-negative breast cancer in association with homologous recombination deficiency.
title_full_unstemmed Integrative analysis of genomic alterations in triple-negative breast cancer in association with homologous recombination deficiency.
title_short Integrative analysis of genomic alterations in triple-negative breast cancer in association with homologous recombination deficiency.
title_sort integrative analysis of genomic alterations in triple negative breast cancer in association with homologous recombination deficiency
url http://europepmc.org/articles/PMC5500377?pdf=render
work_keys_str_mv AT masahitokawazu integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT shinyakojima integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT toshihideueno integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT yasushitotoki integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT hirominakamura integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT akikokunita integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT weiqu integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT junyoshimura integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT manabusoda integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT takahikoyasuda integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT natsukohama integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT mihokosaitoadachi integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT kazuhitosato integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT shinjikohsaka integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT eirinsai integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT masakoikemura integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT shigeruyamamoto integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT tomokoogawa integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT masashifukayama integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT keiichirotada integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT yasuyukiseto integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT shinichimorishita integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT shoichihazama integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT tatsuhiroshibata integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT yoshihiroyamashita integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency
AT hiroyukimano integrativeanalysisofgenomicalterationsintriplenegativebreastcancerinassociationwithhomologousrecombinationdeficiency